Synuclav 400 mg/100 mg Tablets for Dogs

None.

Special precautions for safe use in the target species:
Inappropriate use of the product may increase the prevalence of bacteria resistant to
amoxicillin/clavulanic acid.
In animals with hepatic and renal failure, the dosing regimen should be carefully evaluated.
Use of the product should be based on susceptibility testing and take into account official
and local antimicrobial policies. Narrow spectrum antibacterial therapy should be used for
first line treatment where susceptibility testing suggests likely efficacy of this approach.
Caution is advised in the use in small herbivores other than those in 3.3.
Dogs and cats diagnosed with Pseudomonas infections should not be treated with this
antibiotic combination.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection,
inhalation, ingestion, or skin contact. Hypersensitivity to penicillins may lead to cross-
AN: 00657/2025 & 00662/2025
reactions to cephalosporins and vice versa. Allergic reactions to these substances may
occasionally be serious.
Do not handle this product if you know you are sensitised, or if you have been advised not
to work with such preparations.
Handle this veterinary medicinal product with great care to avoid exposure, taking all
recommended precautions.
If you develop symptoms following exposure such as a skin rash, you should seek medical
advice and show the package leaflet or the label to the physician. Swelling of the face, lips
or eyes or difficulty with breathing are more serious symptoms and require urgent medical
attention.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.